3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
18
Carcinoma, Non-Small-Cell Lung
17
Urinary Bladder Neoplasms
14
Lung Neoplasms
11
Ovarian Neoplasms
10
Nasopharyngeal Carcinoma
9
Neoplasm Metastasis
8
Lymphoma, Large B-Cell, Diffuse
6
Cholangiocarcinoma
6
Biliary Tract Neoplasms
6
Non-Muscle Invasive Bladder Neoplasms
5
Breast Neoplasms
5
Triple Negative Breast Neoplasms
4
Fallopian Tube Neoplasms
4
Endometrial Neoplasms
4
Carcinoma, Transitional Cell
4
Recurrence
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Neoplasms
3
Lymphoma, Non-Hodgkin
3
Colorectal Neoplasms
3
Uterine Cervical Neoplasms
2
Urologic Neoplasms
2
Sarcoma
2
Rectal Neoplasms
2
Osteosarcoma
2
Melanoma
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Leiomyosarcoma
2
Interventions
Radiotherapy
4
Carboplatin
4
Radiation
3
Radiotherapy, Conformal
2
Platinum
2
Pemetrexed
2
Paclitaxel
2
Magnetic Resonance Spectroscopy
2
Immunoglobulin G
2
Disulfides
2
Cisplatin
2
1,2-diaminocyclohexaneplatinum II citrate
2
veliparib
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
methoxyamine
1
durvalumab
1
Taxes
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Nivolumab
1
Metformin
1
Ipilimumab
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Docetaxel
1
CTLA-4 Antigen
1
Biopsy
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma of Lung
×
Gemcitabine
×
30 days
×
Clear all
No trials found.